materials science | Science and Enterprise

A Canadian medical school lab is helping evaluate and develop a pain relief drug made by a company developing thera… https://t.co/HTEdzTQVvO
about 19 hours ago
New post on Science and Enterprise: Industry, Univ Labs Partner on Cannabinoid Pain Drug https://t.co/ZrZF5dm5Ce #Science #Business
about 19 hours ago
https://t.co/037qhZ8zQ2 Go Hawks ... in this case, a sharp-shinned hawk, according to @CornellBirds
about 22 hours ago
An engineering lab created simple and stable control probes to validate widely used diagnostic tests for SARS-Cov-2… https://t.co/NCatkkRGQq
about 23 hours ago
New post on Science and Enterprise: Simpler Method Devised to Validate Covid-19 Tests https://t.co/PC6JYOVo7T #Science #Business
about 23 hours ago

Blood Cells Transport Enzymes to Slow Cancer Spread

By Alan, on November 16th, 2020%

Researchers devised a technique that in lab mice carries immune system enzymes on red blood cells to stop the spread of cancer in the lungs. . . . → Read More: Blood Cells Transport Enzymes to Slow Cancer Spread

Start-Up Gains Drug Nanoparticle Manufacturing Tech

By Alan, on November 13th, 2020%

A new enterprise spun-off from University of Connecticut is acquiring a technology for continuous manufacturing of nanoscale drug particles. . . . → Read More: Start-Up Gains Drug Nanoparticle Manufacturing Tech

Flexible Device Attaches to Heart, Monitors Functions

By Alan, on November 4th, 2020%

Biomedical engineers designed a thin flexible implantable patch that attaches to the heart, monitors its functions, and can perform therapeutics. . . . → Read More: Flexible Device Attaches to Heart, Monitors Functions

Carb-X Funding Nanoscale Sponge to Treat Sepsis

By Alan, on October 21st, 2020%

A company developing tiny particles made of cellular material to soak-up toxins in the body received a $4 million award to advance its sepsis treatment. . . . → Read More: Carb-X Funding Nanoscale Sponge to Treat Sepsis

BARDA Funding Vaccine Patch Clinical Trial

By Alan, on October 5th, 2020%

The U.S. government’s medical preparedness agency is funding a clinical trial of a patch that dispenses vaccines with a much lower dose than syringes. . . . → Read More: BARDA Funding Vaccine Patch Clinical Trial

Wireless Sensor Detects Multiple Covid-19 Indicators

By Alan, on October 2nd, 2020%

Biomedical engineers designed a lab-on-a-chip sensor that quickly detects SARS-CoV-2 viruses in saliva or blood, as well as antibodies and indicators of disease severity. . . . → Read More: Wireless Sensor Detects Multiple Covid-19 Indicators

Small Biz Grant Funds Covid-19 Disinfectant Spray

By Alan, on September 10th, 2020%

A Florida start-up company is developing a fast-acting disinfectant spray that dries on contact, yet still kills Covid-19 viruses on surfaces. . . . → Read More: Small Biz Grant Funds Covid-19 Disinfectant Spray

Venture Fund Plans $350M for Biotech Start-Ups

By Alan, on August 5th, 2020%

A new venture fund plans investments in early-stage life science companies addressing critical needs in therapeutics, but also agriculture and industrial biotechnology. . . . → Read More: Venture Fund Plans $350M for Biotech Start-Ups

Tough Surgical Adhesive Commercially Licensed

By Alan, on July 21st, 2020%

A bio-materials company is acquiring the rights to develop dental sutures and membranes from an adhesive gel developed in a university lab. . . . → Read More: Tough Surgical Adhesive Commercially Licensed

Coating Deactivates Covid-19 Viruses on Surfaces

By Alan, on July 16th, 2020%

A chemical engineering lab developed a coating that when applied to surfaces quickly inactivates viruses responsible for Covid-19 infections. . . . → Read More: Coating Deactivates Covid-19 Viruses on Surfaces

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise